Paper31866622
T-cell large granular lymphocytic (LGL) leukemia consists of CD4+/CD8dim and CD4-/CD8+ LGL populations in association with immune thrombocytopenia, autoimmune neutropenia, and monoclonal B-cell lymphocytosis.
Kuwahara N and 13 others. J Clin Exp Hematop, 2019. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. T-cell large granular lymphocytic (LGL) leukemia consists of CD4+/CD8dim and CD4-/CD8+ LGL populations in association with immune thrombocytopenia, autoimmune neutropenia, and monoclonal B-cell lymphocytosis. Papers, record 31866622. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31866622
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
T-cell large granular lymphocytic (LGL) leukemia consists of CD4+/CD8dim and CD4-/CD8+ LGL populations in association with immune thrombocytopenia, autoimmune neutropenia, and monoclonal B-cell lymphocytosis.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| B-Lymphocytes | Major topic |
| CD4-Positive T-Lymphocytes | Major topic |
| CD8-Positive T-Lymphocytes | Major topic |
| Leukemia, Large Granular Lymphocytic | Major topic |
| Lymphocytosis | Major topic |
| Mutation, Missense | Major topic |
| Neoplasm Proteins | Major topic |
| Neutropenia | Major topic |
| Purpura, Thrombocytopenic, Idiopathic | Major topic |
| STAT3 Transcription Factor | Major topic |
| Aged, 80 and over | |
| Amino Acid Substitution | |
| Female | |
| Humans | |
| Immunoglobulin lambda-Chains |
Source PubMed
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18776905 | ThPOK acts late in specification of the helper T cell lineage and suppresses Runx-mediated commitment to the cytotoxic T cell lineage. | Nat Immunol | 2008 | https://conductscience.org/library/papers/18776905 | PubMed |
| 2 | 30859397 | STAT3 mutations in natural killer cells are associated with cytopenia in patients with chronic lymphoproliferative disorder of natural killer cells. | Int J Hematol | 2019 | https://conductscience.org/library/papers/30859397 | PubMed |
| 3 | 23667847 | A case of CD4(+)T-cell large granular lymphocytic leukemia. | Ann Lab Med | 2013 | https://conductscience.org/library/papers/23667847 | PubMed |
| 4 | 11435321 | Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes. | Blood | 2001 | https://conductscience.org/library/papers/11435321 | PubMed |
| 5 | 24350896 | STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia. | Cancer Sci | 2014 | https://conductscience.org/library/papers/24350896 | PubMed |
| 6 | 22591296 | Somatic STAT3 mutations in large granular lymphocytic leukemia. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22591296 | PubMed |
| 7 | 7522625 | CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia. | Blood | 1994 | https://conductscience.org/library/papers/7522625 | PubMed |
| 8 | 22688448 | Monoclonal B-cell lymphocytosis (MBL, CD4+/CD8 weak T-cell large granular lymphocytic leukemia (T-LGL leukemia) and monoclonal gammopathy of unknown significance (MGUS): molecular and flow cytometry characterization of three concomitant hematological disorders. | Med Oncol | 2012 | https://conductscience.org/library/papers/22688448 | PubMed |
| 9 | 26022501 | A unique CD4+ large granular lymphocytosis occurring in patients treated with tumor necrosis factor α inhibitors: report of 2 cases. | Hum Pathol | 2015 | https://conductscience.org/library/papers/26022501 | PubMed |
| 10 | 8978299 | The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. | Blood | 1997 | https://conductscience.org/library/papers/8978299 | PubMed |
| 11 | 27697773 | High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia. | Blood | 2016 | https://conductscience.org/library/papers/27697773 | PubMed |
| 12 | 23596048 | Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia. | Blood | 2013 | https://conductscience.org/library/papers/23596048 | PubMed |
| 13 | 25360000 | CD4+/CD8+ double-positive T cells: more than just a developmental stage? | J Leukoc Biol | 2015 | https://conductscience.org/library/papers/25360000 | PubMed |
| 14 | 19062319 | The zinc finger transcription factor Zbtb7b represses CD8-lineage gene expression in peripheral CD4+ T cells. | Immunity | 2008 | https://conductscience.org/library/papers/19062319 | PubMed |
| 15 | 22859607 | STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. | Blood | 2012 | https://conductscience.org/library/papers/22859607 | PubMed |
| 16 | 24283217 | STAT3 mutations are frequent in T-cell large granular lymphocytic leukemia with pure red cell aplasia. | J Hematol Oncol | 2013 | https://conductscience.org/library/papers/24283217 | PubMed |
| 17 | 7819080 | A biclonal large granular lymphocyte (LGL)/NK-associated (NKa) disorder of CD4+ and CD8+ lymphocyte subpopulations characterized by the simultaneous presence of distinct TCR rearrangements. | Br J Haematol | 1994 | https://conductscience.org/library/papers/7819080 | PubMed |
| 18 | 12875995 | TCRalphabeta+/CD4+ large granular lymphocytosis: a new clonal T-cell lymphoproliferative disorder. | Am J Pathol | 2003 | https://conductscience.org/library/papers/12875995 | PubMed |
| 19 | 28115367 | LGL leukemia: from pathogenesis to treatment. | Blood | 2017 | https://conductscience.org/library/papers/28115367 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41585259 | Comparison of the efficacy of thalidomide combined with low-dose rituximab and low-dose rituximab alone in the treatment of steroid-resistant/refractory adult patients with primary immune thrombocytopenia: an open-label trial. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/41585259 | PubMed |
| 40537729 | The causal relationship between circulating inflammatory proteins, gut microbiotas, immune cells and leukemia: a bidirectional Mendelian randomization study. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40537729 | PubMed |
| 38610985 | Large Granular Lymphocytic Leukemia: Clinical Features, Molecular Pathogenesis, Diagnosis and Treatment. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38610985 | PubMed |
| 35210405 | Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia. | Blood Cancer J | 2022 | https://conductscience.org/library/papers/35210405 | PubMed |
| 34572739 | The Value of Flow Cytometry Clonality in Large Granular Lymphocyte Leukemia. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34572739 | PubMed |
Genes24
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31866622
GET https://conductscience.org/api/papers/v1/31866622/genes?page=2